Literature DB >> 1519988

Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.

N C Austin1, P W Pairaudeau, T K Hames, M A Hall.   

Abstract

Cerebral blood flow velocity was assessed during infusion of indomethacin over 30 minutes. Eleven preterm infants with symptomatic patent ductus arteriosus were studied on 12 occasions. Indomethacin infusion was associated with a significant reduction in time averaged mean velocity (TAMV), peak systolic velocity (PSV), and end diastolic velocity in both the anterior cerebral artery and middle cerebral artery. The fall in the TAMV and PSV was gradual with maximal change 30-40 minutes after the start of the infusion. It was concluded that administration of indomethacin by slow infusion produces haemodynamic alterations to the cerebral circulation comparable in magnitude with changes described with bolus administration. Indomethacin remains a useful and effective treatment for patent ductus arteriosus in preterm infants, but should continue to be used with caution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519988      PMCID: PMC1590416          DOI: 10.1136/adc.67.7_spec_no.851

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Absolute intracranial blood-flow velocities evaluated by duplex Doppler sonography in asymptomatic preterm and term neonates.

Authors:  J G Horgan; C M Rumack; T Hay; M L Manco-Johnson; G B Merenstein; C Esola
Journal:  AJR Am J Roentgenol       Date:  1989-05       Impact factor: 3.959

2.  Effects of indomethacin on cerebral haemodynamics in very preterm infants.

Authors:  A D Edwards; J S Wyatt; C Richardson; A Potter; M Cope; D T Delpy; E O Reynolds
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

3.  Major pitfalls in Doppler investigations with particular reference to the cerebral vascular system. Part I. Sources of error, resulting pitfalls and measures to prevent errors.

Authors:  P Winkler; K Helmke
Journal:  Pediatr Radiol       Date:  1990

4.  Resistance index, blood flow velocity, and resistance-area product in the cerebral arteries of very low birth weight infants during the first week of life.

Authors:  D H Evans; M I Levene; D B Shortland; L N Archer
Journal:  Ultrasound Med Biol       Date:  1988       Impact factor: 2.998

5.  Indomethacin, patent ductus arteriosus, and cerebral blood flow.

Authors:  F Cowan
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

6.  Effect of indomethacin on cerebral blood flow velocity of premature newborns.

Authors:  N Laudignon; S Chemtob; H Bard; J V Aranda
Journal:  Biol Neonate       Date:  1988

7.  Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect.

Authors:  F Van Bel; M Van de Bor; T Stijnen; J Baan; J H Ruys
Journal:  Pediatrics       Date:  1989-11       Impact factor: 7.124

8.  Cerebral blood flow following indomethacin administration.

Authors:  B P Lundell; S E Sonesson; H Sundell
Journal:  Dev Pharmacol Ther       Date:  1989

9.  Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates.

Authors:  P Colditz; D Murphy; P Rolfe; A R Wilkinson
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

10.  Carbon dioxide reactivity of the cerebral circulation in extremely premature infants: effects of postnatal age and indomethacin.

Authors:  M I Levene; D Shortland; N Gibson; D H Evans
Journal:  Pediatr Res       Date:  1988-08       Impact factor: 3.756

View more
  9 in total

Review 1.  Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.

Authors:  C Hammerman; M Kaplan
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.

Authors:  Karen E Corff; Kris C Sekar
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

Review 3.  Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.

Authors:  Palmer G Johnston; Maria Gillam-Krakauer; M Paige Fuller; Jeff Reese
Journal:  Clin Perinatol       Date:  2012-01-13       Impact factor: 3.430

4.  Change in blood pressure after treatment of patent ductus arteriosus with indomethacin.

Authors:  N Evans; P Iyer
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

Review 5.  Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Authors:  Ronald I Clyman; James Couto; Gail M Murphy
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

6.  Multiple courses of indomethacin and neonatal outcomes in premature infants.

Authors:  Madhavi Sangem; Sumita Asthana; Sanjiv Amin
Journal:  Pediatr Cardiol       Date:  2007-12-18       Impact factor: 1.655

7.  The effect of dexamethasone on time averaged mean velocity in the middle cerebral artery in very low birth weight infants.

Authors:  A Ohlsson; J Bottu; J Govan; M L Ryan; T Myhr; K Fong
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

Review 8.  Comparative tolerability of pharmacological treatments for patent ductus arteriosus.

Authors:  C Hammerman; M Kaplan
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 9.  Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants.

Authors:  A S Görk; R A Ehrenkranz; M B Bracken
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.